Analyst Coverage Initiated: TNYA rating Buy by H.C. Wainwright
Price Target: $25
Report Date: 06-15-2022
Symbol: TNYA - Tenaya Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Analyst Coverage Initiated: TNYA rating Buy by H.C. Wainwright
Price Target: $25
Tenaya Therapeutics, Inc. (TNYA)
171 Oyster Point Boulevard
South San Francisco, CA
Phone: 760 310 9976
Website: http://www.tenayatherapeutics.com
CEO:
NASDAQ, Nasdaq Global Select
Tenaya Therapeutics, Inc. develops therapeutics for heart failure. It offers cellular regeneration platform, that enables in vivo reprogramming of cardiac fibroblasts into cardio myocytes by delivering proprietary transcription factors; gene therapy platform, that enables the targeted delivery of a payload to cardiac fibroblasts; and precision medicine platform, which provides personalized medicine approach to treat heart disease. The company was incorporated in 2016 and is based in South San Francisco, California.
daily stock signals, best stock trading signals, stock trading signals, free stock trading signals
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228